Stay updated on Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page.

Latest updates to the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page
- CheckyesterdayChange DetectedThe addition '2015 ( U.S. NIH Grant/Contract )' was added to the Other Study ID Numbers to indicate NIH funding for the study.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now shows Revision: v3.6.5, indicating a new version tag. The older revision tag Revision: v3.6.4 and related topic items (Lung cancer, MedlinePlus Genetics) were removed.SummaryDifference0.1%

- Check22 days agoChange DetectedThe page gains new related-topic links for Lung cancer and MedlinePlus Genetics. These additions expand external resource connections.SummaryDifference0.1%

- Check29 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a small backend or formatting update to the page. No changes to the study details or visible content are introduced.SummaryDifference0.0%

- Check36 days agoChange DetectedThe related topics section including Lung cancer and MedlinePlus Genetics was removed, reducing the set of quick links available for context on the study page.SummaryDifference0.1%

- Check50 days agoChange DetectedRelated topics section now includes links for Lung cancer and MedlinePlus Genetics, providing quick access to additional educational resources related to the study's focus.SummaryDifference0.1%

Stay in the know with updates to Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page.